Brief: Paxman Limb Cryocompression System To Be Used In Swog Cancer Research Network Study Testing
Nov 15 (Reuters) - Paxman AB (publ) PAX.ST :
* PAXMAN LIMB CRYOCOMPRESSION SYSTEM TO BE USED IN SWOG
CANCER
RESEARCH NETWORK STUDY TESTING FOR PREVENTION OF
CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
* HAVE BEEN SELECTED BY SWOG CANCER RESEARCH NETWORK, AN
INDEPENDENT GLOBAL CANCER RESEARCH COMMUNITY
Source text for Eikon: ID:nMFNbjG68h
Further company coverage: PAX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Paxman AB (publ)
See all newsBrief: Paxman Secures First Uk Orders For Neuropathy System
Sweden's Paxman Q2 revenue rises 40% as net income turns positive
Brief: Paxman Reports Q2 Group Revenue Of SEK 105 Million
Brief: Paxman Says CMS Releases Cy2027 Proposed OPPS, MPFS Rules For Mechanical Scalp Cooling
Sweden's Paxman Q1 revenue rises 34% on Dignitana acquisition